National Institute of Mental Health
This effort aims to stimulate research in a major gap area in pediatric psychopharmacology for psychiatric and neurodevelopmental disorders, by encouraging the development of objective pediatric central nervous system (CNS) measures that can be incorporated into pharmacologic trials.
This is a re-issue of a long-standing R25 program announcement. The overarching goals of this initiative are to: (1) complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs; (2) help recruit individuals with specific specialty or disciplinary backgrounds to research careers in biomedical, behavioral, and clinical sciences; and (3) foster a better understanding of biomedical, behavioral, and clinical research and its implications.
The purpose of the Conte Centers program is to support interdisciplinary teams of researchers engaged in novel, creative, and integrated experimental approaches to address high-risk, high-impact scientific questions in either basic neuroscience research or in translational research that will significantly advance the state of the science in brain and behavioral research and provide the foundation for understanding mental disorders and/or transform the understanding and treatment of mental illnesses.
